Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ecker

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Movement Disorders : Official Journal of the Movement Disorder Society|August 28, 2007
Cocaine- and amphetamine-regulated transcript is increased in Huntington diseaseMaria Björkqvist, Blair R Leavitt, Jörgen E Nielsen, et al.
Neuroimage|July 5, 2011
Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball taskFrancesco Musso, Jürgen Brinkmeyer, Daniel Ecker, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2011
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidatePaul Ratcliffe, Julia M Adam, James Baker, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Movement Disorders : Official Journal of the Movement Disorder Society|August 28, 2007
Cocaine- and amphetamine-regulated transcript is increased in Huntington diseaseMaria Björkqvist, Blair R Leavitt, Jörgen E Nielsen, et al.
Neuroimage|July 5, 2011
Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball taskFrancesco Musso, Jürgen Brinkmeyer, Daniel Ecker, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2011
Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidatePaul Ratcliffe, Julia M Adam, James Baker, et al.
Pageof 2